Literature DB >> 22969926

CREST biorepository for translational studies on malignant mesothelioma, lung cancer and other respiratory tract diseases: Informatics infrastructure and standardized annotation.

Donatella Ugolini1, Monica Neri, Luca Bennati, Pier Aldo Canessa, Georgia Casanova, Cecilia Lando, Giacomo Leoncini, Paola Marroni, Barbara Parodi, Claudio Simonassi, Stefano Bonassi.   

Abstract

Advances in molecular epidemiology and translational research have led to the need for biospecimen collection. The Cancer of the Respiratory Tract (CREST) biorepository is concerned with pleural malignant mesothelioma (MM) and lung cancer (LC). The biorepository staff has collected demographic and epidemiological data directly from consenting subjects using a structured questionnaire, in agreement with The Public Population Project in Genomics (P(3)G). Clinical and follow-up data were collected. Sample data were also recorded. The architecture is based on a database designed with Microsoft Access. Data standardization was carried out to conform with established conventions or procedures. As from January 31, 2011, the overall number of recruited subjects was 1,857 (454 LC, 245 MM, 130 other cancers and 1,028 controls). Due to its infrastructure, CREST was able to join international projects, sharing samples and/or data with other research groups in the field. The data management system allows CREST to be involved, through a minimum data set, in the national project for the construction of the Italian network of Oncologic BioBanks (RIBBO), and in the infrastructure of a pan-European biobank network (BBMRI). The CREST biorepository is a valuable tool for translational studies on respiratory tract diseases, because of its simple and efficient infrastructure.

Entities:  

Year:  2011        PMID: 22969926      PMCID: PMC3438688          DOI: 10.3892/etm.2011.416

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  18 in total

Review 1.  Biobanking for Europe.

Authors:  Martin Yuille; Gert-Jan van Ommen; Christian Bréchot; Anne Cambon-Thomsen; Georges Dagher; Ulf Landegren; Jan-Eric Litton; Markus Pasterk; Leena Peltonen; Mike Taussig; H-Erich Wichmann; Kurt Zatloukal
Journal:  Brief Bioinform       Date:  2007-10-23       Impact factor: 11.622

2.  Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.

Authors:  Gretchen V Gee; Devin C Koestler; Brock C Christensen; David J Sugarbaker; Donatella Ugolini; Giovanni P Ivaldi; Murray B Resnick; E Andres Houseman; Karl T Kelsey; Carmen J Marsit
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

4.  Incidence of pleural mesothelioma in Liguria Region, Italy (1996-2002).

Authors:  V Gennaro; D Ugolini; P Viarengo; L Benfatto; M Bianchelli; A Lazzarotto; F Montanaro; R Puntoni
Journal:  Eur J Cancer       Date:  2005-10-21       Impact factor: 9.162

5.  miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.

Authors:  Kristen M Foss; Chao Sima; Donatella Ugolini; Monica Neri; Kristi E Allen; Glen J Weiss
Journal:  J Thorac Oncol       Date:  2011-03       Impact factor: 15.609

6.  The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases.

Authors:  Donatella Ugolini; Ugolini Donatella; Monica Neri; Neri Monica; Pier Aldo Canessa; Canessa Pier Aldo; Cristina Casilli; Casilli Cristina; Giuseppe Catrambone; Catrambone Giuseppe; Giovanni Paolo Ivaldi; Ivaldi Giovanni Paolo; Cecilia Lando; Lando Cecilia; Paola Marroni; Marroni Paola; Michela Paganuzzi; Paganuzzi Michela; Barbara Parodi; Parodi Barbara; Paola Visconti; Visconti Paola; Riccardo Puntoni; Puntoni Riccardo; Stefano Bonassi; Bonassi Stefano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

7.  SV40 associated miRNAs are not detectable in mesotheliomas.

Authors:  G V Gee; M L Stanifer; B C Christensen; W J Atwood; D Ugolini; S Bonassi; M B Resnick; H H Nelson; C J Marsit; K T Kelsey
Journal:  Br J Cancer       Date:  2010-08-17       Impact factor: 7.640

Review 8.  Biological sample collection and processing for molecular epidemiological studies.

Authors:  Nina T Holland; Martyn T Smith; Brenda Eskenazi; Maria Bastaki
Journal:  Mutat Res       Date:  2003-06       Impact factor: 2.433

9.  Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism.

Authors:  Federica Gemignani; Monica Neri; Fabio Bottari; Roberto Barale; Pier Aldo Canessa; Federico Canzian; Marcello Ceppi; Irene Spitaleri; Monica Cipollini; Gian Paolo Ivaldi; Manlio Mencoboni; Paola Scaruffi; Gian Paolo Tonini; Donatella Ugolini; Luciano Mutti; Stefano Bonassi; Stefano Landi
Journal:  Mutat Res       Date:  2009-09-12       Impact factor: 2.433

10.  Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer.

Authors:  Alfonso Cristaudo; Rudy Foddis; Agnese Vivaldi; Giovanni Guglielmi; Nicola Dipalma; Rosangela Filiberti; Monica Neri; Marcello Ceppi; Michela Paganuzzi; Gian Paolo Ivaldi; Manlio Mencoboni; Pier Aldo Canessa; Nicolino Ambrosino; Antonio Chella; Luciano Mutti; Riccardo Puntoni
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

View more
  1 in total

Review 1.  Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma - A Review.

Authors:  Ben William Johnson; Ken Takahashi; Yuen Yee Cheng
Journal:  Front Oncol       Date:  2021-11-11       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.